Home / Tag Archives: Diabetes complications

Tag Archives: Diabetes complications

Frozen Shoulder and Diabetes: The Overlooked Complication That Can Steal Mobility

Woman with diabetes experiencing shoulder pain from diabetic shoulder adhesive capsulitis, also known as frozen shoulder.

Diabetes complications are often discussed in terms of the heart, kidneys, eyes, and nerves. However, diabetes can also affect joints and connective tissue. Adhesive capsulitis, or frozen shoulder, is one diabetes-related complication that deserves more attention. It can begin with ordinary shoulder pain and gradually make simple movements surprisingly difficult. …

Read More »

Beyond Pain Relief: Can Spinal Cord Stimulation Restore Sensation in Diabetic Neuropathy?

Medical illustration of spinal cord stimulation for diabetic neuropathy showing nerve pathways, foot sensation, and an implanted stimulator.

For people with painful diabetic neuropathy (PDN), treatment has traditionally focused on controlling burning, stabbing, and shooting pain. However, emerging research on spinal cord stimulation for diabetic neuropathy raises a more intriguing question: Could neuromodulation also improve sensation? Results from the SENZA-PDN clinical trial suggest that some patients receiving high-frequency …

Read More »

Could a Simple Blood Test Predict a Heart Event in Type 2 Diabetes?

Blood sample illustrating epigenetic cardiovascular risk prediction using DNA methylation to assess heart risk in type 2 diabetes.

Could a routine blood sample someday reveal cardiovascular danger that cholesterol, blood pressure, and HbA1c do not fully capture? New research suggests that epigenetic cardiovascular risk prediction could offer a new way to identify people with type 2 diabetes who face a higher short-term risk of major cardiovascular events. Instead …

Read More »

Three Decades of Better Type 1 Diabetes Care: Have Complications Actually Declined?

Person with type 1 diabetes using modern glucose monitoring technology, illustrating advances in care and long-term complication prevention.

Three decades of advances in diabetes care have transformed how people with type 1 diabetes manage glucose. Insulin pumps, continuous glucose monitoring (CGM), improved insulin analogs, automated insulin delivery, and earlier screening have all changed daily treatment. However, have these advances actually reduced the long-term complications of type 1 diabetes? …

Read More »

One Drug Isn’t Enough: When Should Clinicians Combine Treatments for Painful Diabetic Neuropathy?

Clinician discussing diabetic neuropathy pain treatment and combination therapy options with a patient using an anatomical foot model.

Finding the right diabetic neuropathy pain treatment can be challenging when a well-chosen first medication provides only partial relief. Burning, shooting pain, tingling, and allodynia can continue to disrupt sleep, mobility, mood, and daily function. Fortunately, clinicians do not always have to choose between abandoning a partially effective drug and …

Read More »

Diagnosed Younger: Does Type 1 Onset Shape Later Risk?

Child, teenager, and adult with type 1 diabetes illustrating how age at onset may relate to long-term complication risks.

Does being diagnosed with type 1 diabetes at age 6 carry the same long-term risks as being diagnosed at 16? Researchers have been asking that question for years. Increasingly, evidence suggests that age at type 1 diabetes onset may help explain differences in complication patterns later in life. However, age …

Read More »

Beyond hs-CRP: Could suPAR Reveal Hidden Heart Risk in Type 2 Diabetes?

suPAR biomarker blood test with heart model and glucose meter representing cardiovascular risk in type 2 diabetes

People with type 2 diabetes can face substantial cardiovascular risk even when clinicians address familiar risk factors such as LDL cholesterol, blood pressure, smoking, and blood glucose. Could another blood marker help reveal some of the risk that remains? Emerging research on the suPAR biomarker in diabetes suggests it may …

Read More »

Normal Blood Sugar, But Still in DKA? The Hidden Danger of Euglycemic Ketoacidosis

Euglycemic DKA SGLT2 inhibitor concept showing normal blood glucose, elevated ketones, medication, and kidney model.

Euglycemic diabetic ketoacidosis can challenge one of the most familiar clinical shortcuts in diabetes care: DKA should come with markedly elevated glucose. In patients taking sodium-glucose cotransporter 2 (SGLT2) inhibitors, however, dangerous ketoacidosis may develop while glucose remains normal or only modestly elevated. As a result, euglycemic DKA in patients …

Read More »